Pre-Formulation Intermediates (PFIs)
PFIs designed with robust stability, solubility, and manufacturability as core attributes, serving as the backbone for high-quality finished dosage forms.
Products
Finished Formulations for Tech Transfer
Development and technology transfer of solid and liquid dosage forms with emphasis on stability, patient compliance, and regulatory readiness.
Examples under development:
- • Linaclotide Capsules – IBS
- • Semaglutide Tablets – Type 2 Diabetes
- • Metformin / Empagliflozin / Linagliptin MR Tablets – Anti-diabetic